Leaders from OpenAI, Anthropic, Google DeepMind, and Microsoft AI have signed an open letter urging the establishment of mandatory checks for clients and orders from suppliers of synthetic DNA and RNA. This was reported by WIRED.
According to the publication, the appeal was supported by Sam Altman (OpenAI), Dario Amodei (Anthropic), Demis Hassabis (Google DeepMind), and Mustafa Suleyman (Microsoft AI). The signatories also include scientists, national security experts, and representatives from the gene synthesis industry.
The authors of the initiative proposed requiring suppliers to screen orders for synthetic nucleic acids and keep records of such transactions. The letter emphasizes the need for client identity verification and control over equipment.
The appeal states that the rapid development of AI lowers "knowledge barriers," potentially enabling malicious actors to use neural networks to design dangerous pathogens and toxins, circumventing previous restrictions. Order screening is identified as one of the most effective and "least burdensome" methods to mitigate biological threats.
WIRED noted that some companies (such as Twist Bioscience) conduct such checks voluntarily as part of an industry consortium, but there are no unified federal regulations in the U.S.
Previously, a bipartisan bill was introduced in the Senate that would require all gene synthesis providers in the country to check their counterparts for ties to terrorist organizations or attempts to recreate dangerous viruses.
It is worth noting that in June 2025, one of the largest medical charities, Wellcome Trust, allocated £10 million to launch the world's first project aimed at creating parts or even entire DNA from scratch.